Categories AlphaGraphs, Earnings, Energy

Infographic: Highlights of Exxon Mobil’s (XOM) Q3 earnings report

Energy exploration company Exxon Mobil Corporation (NYSE: XOM) reported a net loss for the third quarter of 2020 as revenues were impacted by the pandemic-induced disruption. However, the results came in above analysts’ projection.

Exxon Mobil Q3 2020 earnings infographic

Net loss attributable to ExxonMobil was $0.18 per share in the September-quarter, on an adjusted basis, compared to earnings of $0.68 per share in the corresponding period of last year. Unadjusted net loss was $680 million or $0.15 per share, compared to a profit of $3.17 billion or $0.75 per share a year earlier. Analysts had forecast a wider loss for the latest quarter.

The bottom-line was hurt by a 29% decline in revenues to $46.2 billion. The top-line came in above the market’s projection.

Read management/analysts’ comments on Altria’s Q3 results

Exxon Mobil’s stock closed the last trading session higher but slipping into the negative territory on Friday morning, following the earnings announcement.

  • exxonmobil Q3 2019 earnings infographic
  • ExxonMobil Q2 profit drops 21% but beats estimates

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

PM Earnings: Key quarterly highlights from Philip Morris Q3 financial results

Philip Morris International Inc. (NYSE: PM) reported Third-quarter 2021 earnings results today. Net revenues increased 9% year-over-year to $8.1 billion. The reported net income amounted to $2.42 billion compared to

Halliburton stock slips on weaker-than-expected Q3 results

Halliburton (NYSE: HAL) reported third-quarter 2021 financial results before the regular market hours on Tuesday. The company reported Q3 revenue of $3.9 billion, up 30% year-over-year and lower than the

Johnson & Johnson (JNJ) reports Q3 2021 earnings

Johnson & Johnson (NYSE: JNJ) reported third-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue of $23.3 billion, up 10.7% year-over-year, with operational

Add Comment
Viewing Highlight